PTK2 and neoplasm: miR-7 also directly targets insulin-like growth factor 1 receptor (IGF1R) [53], FAK [54], and PAK1 [55], which can inhibit the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of tumor cells.